Friday, January 30, 2026 at 12:00 PM
This grand round has already taken place.
January 30th, 2026 1.00 AMA PRA Category 1 Credit™ Hours
Description
1.Discuss the implications of the FDA Modernization Act 2.0 to cardiovascular research.
2.Discuss the role of human induced pluripotent stem cells in cardiovascular research.
3.Discuss the role of engineered heart tissues in improving in vitro cardiomyopathy models.
Dates and Times
Start: 1/30/2026 12:00 PM
End: 1/30/2026 1:00 PM
Objectives
1.Discuss the implications of the FDA Modernization Act 2.0 to cardiovascular research.
2.Discuss the role of human induced pluripotent stem cells in cardiovascular research.
3.Discuss the role of engineered heart tissues in improving in vitro cardiomyopathy models.
Speakers
Location
Ross Auditorium
452 W 1Oth Ave
452 W 1Oth Ave
Columbus, OH 43210
Accreditation Statement
The Ohio State University is accredited by the Accreditation Council for Continuing Medical Education (ACCME®) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The Ohio State University designates this live activity for a maximum of 1.00 AMA PRA Category 1 Credit(s) ™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Need help with this Grand Round Session?
Please contact the Grand Round coordinator listed below:
Allison Robinson
Email: allison.robinson@osumc.edu